Evidence Based Medicine on FHIR Implementation Guide
1.0.0-ballot3 - STU 1 Ballot 3 World

Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 1.0.0-ballot3 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions

Evidence: MAGIC-derived Evidence: Health-related quality of life with SGLT2 inhibitors vs. GLP-1 RA in Adults with type 2 diabetes

Official URL: https://fevir.net/resources/Evidence/236984 Version: 1.0.0-ballot3
Standards status: Informative Computable Name: Health_related_quality_of_life_from_MAGICapp_109587
Other Identifiers: FEvIR Object Identifier: FEvIR Object Identifier#236984, outcomeId: 109587, picoId: 85798, sectionId: 73215, OID:2.16.840.1.113883.4.642.40.44.22.158

Usage: Evidence Communication: ComparativeEvidence

Copyright/Legal: Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).

This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.

version: 72; Last updated: 2026-08-06 17:15:59+0000

Profile: ComparativeEvidence

ArtifactPublicationStatus: Active

url: Evidence MAGIC-derived Evidence: Health-related quality of life with SGLT2 inhibitors vs. GLP-1 RA in Adults with type 2 diabetes

identifier: FEvIR Object Identifier/236984, outcomeId/109587, picoId/85798, sectionId/73215, Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.44.22.158

version: 1.0.0-ballot3

name: Health_related_quality_of_life_from_MAGICapp_109587

title: MAGIC-derived Evidence: Health-related quality of life with SGLT2 inhibitors vs. GLP-1 RA in Adults with type 2 diabetes

citeAs:

MAGIC-derived Evidence: Health-related quality of life with SGLT2 inhibitors vs. GLP-1 RA in Adults with type 2 diabetes [Database Entry: FHIR Evidence Resource]. Contributors: Computable Publishing®: MAGIC-to-FEvIR Converter [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 236984. Revised 2026-08-06. Available at: https://fevir.net/resources/Evidence/236984. Computable resource at: https://fevir.net/resources/Evidence/236984#json.

status: Active

date: 2026-11-05 14:34:28+0000

author: Computable Publishing®: MAGIC-to-FEvIR Converter:

publisher: HL7 International / Clinical Decision Support

contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss

UseContexts

-CodeValue[x]
*Evidence Based Medicine on FHIR Implementation Guide Code System: evidence-communication (Evidence Communication)ComparativeEvidence

copyright:

Copyright the Authors else Computable Publishing LLC. Noncommercial use permitted with CC BY-NC-SA 4.0 (https://creativecommons.org/licenses/by-nc-sa/4.0/). Commercial use permitted as agreed in Terms of Use (https://fevir.net/termsofuse).

RelatesTos

-TypeTarget[x]
*Part OfMAGICapp Conversion Report: SGLT2 inhibitors and GLP-1 RA for type 2 diabetes (Identifier: FEvIR Linking Identifier/MAGIC-5288-j1Wqrn-conversion-report)

description:

This Evidence Resource is referenced in an example for the EBMonFHIR Implementation Guide.

assertion:

There may be no important difference between SGLT2 inhibitors and GLP-1 receptor agonists on health-related quality of life.

variableDefinition

description:

Adults with type 2 diabetes

variableRole: Population

observed: Adults with type 2 diabetes and CVD and CKD

variableDefinition

description:

GroupAssignment: SGLT2 inhibitors vs. GLP-1 RA

variableRole: Exposure

comparatorCategory: GLP-1 RA

observed: GroupAssignment: SGLT2 inhibitors vs. GLP-1 RA

variableDefinition

description:

Health-related quality of life

variableRole: Outcome

observed: Health-related quality of life

synthesisType: SYSTEMATIC_REVIEW

studyDesign: NOTSET

statistic

description:

SMD 0.01 (CI95 -0.19 to 0.2 )

statisticType: standardized mean difference

quantity: 0.01

AttributeEstimates

-TypeRange
*CI95-0.19-0.2

certainty

description:

Due to very serious imprecision

type: Overall certainty

rating: Low certainty

Subcomponents

-TypeRating
*Risk of BiasNOTSET
*InconsistencyNOTSET
*IndirectnessNOTSET
*ImprecisionVERY_SERIOUS
*Publication BiasNOTSET